Protocol Ledger

NCT07328841 · Phase III · RECRUITING

Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy

Interventional Phase III clinical trial protocol NCT07328841 sponsored by Ming-Yuan Chen in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-11-18 Enrollment: 456 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07328841
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)456 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)1 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07328841
Protocol FieldVerified Registry Value
NCT IdentifierNCT07328841
Consolidated Lead SponsorMing-Yuan Chen
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment456 participants (ESTIMATED)
Registered Start Date2025-11-18
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT07328841
Hospital Research SiteLocationSite Profile
Sun Yat-sen University Cancer CenterGuangzhou, ChinaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI